CoreTissue BioEngineering Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Series AA
- Latest Deal Amount
-
$3.93M
- Investors
-
14
CoreTissue BioEngineering General Information
Description
Developer of implantable artificial ligaments designed for anterior cruciate ligament reconstruction. The company develops artificial ligaments that are used for the reconstruction of anterior knee cruciate ligaments using decellularized tissue that removes cellular components from biological tissues and then transplants them into the body, enabling patients to have a reconstruction of the anterior knee cruciate ligaments and lead a healthy lifestyle.
Contact Information
Website
www.coretissue.comCorporate Office
- 301 Life Science Research Center
- 1-1-43 Suehirocho, Tsurumi-ku
- Yokohama, Kanagawa 230-0045
- Japan
Corporate Office
- 301 Life Science Research Center
- 1-1-43 Suehirocho, Tsurumi-ku
- Yokohama, Kanagawa 230-0045
- Japan
CoreTissue BioEngineering Timeline
CoreTissue BioEngineering Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series AA) | 10-Nov-2025 | $3.93M | Completed | Clinical Trials - Phase 3 | ||
| 6. Accelerator/Incubator | 30-Jul-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 24-Feb-2023 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 08-Aug-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 20-Oct-2021 | Completed | Generating Revenue | |||
| 2. Seed Round | 16-Oct-2019 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 29-Nov-2016 | Completed | Startup |
CoreTissue BioEngineering Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A preferred |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
CoreTissue BioEngineering Patents
CoreTissue BioEngineering Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2025158851-A | Sterile container lid | Pending | 05-Apr-2024 | ||
| JP-7432981-B2 | Container for biological tissue storage | Active | 06-Oct-2021 | ||
| EP-4327656-A1 | Container for storing biological tissue | Pending | 06-Oct-2021 | ||
| EP-4327656-A4 | Container for storing biological tissue | Pending | 06-Oct-2021 | ||
| US-20240246744-A1 | Container for storing biological tissue | Pending | 06-Oct-2021 | A01N1/146 |
CoreTissue BioEngineering Signals
CoreTissue BioEngineering Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mitsui Sumitomo Kaijo Capital | Corporate Venture Capital | Minority | ||
| MMA Investment Limited | Corporation | Minority | ||
| NH Foods | Corporation | Minority | ||
| Waseda University Ventures | Venture Capital | Minority | ||
| Mitsubishi | Corporation | Minority |
CoreTissue BioEngineering FAQs
-
When was CoreTissue BioEngineering founded?
CoreTissue BioEngineering was founded in 2016.
-
Where is CoreTissue BioEngineering headquartered?
CoreTissue BioEngineering is headquartered in Yokohama, Japan.
-
What is the size of CoreTissue BioEngineering?
CoreTissue BioEngineering has 25 total employees.
-
What industry is CoreTissue BioEngineering in?
CoreTissue BioEngineering’s primary industry is Therapeutic Devices.
-
Is CoreTissue BioEngineering a private or public company?
CoreTissue BioEngineering is a Private company.
-
What is the current valuation of CoreTissue BioEngineering?
The current valuation of CoreTissue BioEngineering is .
-
What is CoreTissue BioEngineering’s current revenue?
The current revenue for CoreTissue BioEngineering is .
-
How much funding has CoreTissue BioEngineering raised over time?
CoreTissue BioEngineering has raised $8.19M.
-
Who are CoreTissue BioEngineering’s investors?
Mitsui Sumitomo Kaijo Capital, MMA Investment Limited, NH Foods, Waseda University Ventures, and Mitsubishi are 5 of 14 investors who have invested in CoreTissue BioEngineering.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process